PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 183 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $36,000 | -62.9% | 5,065 | +25.2% | 0.01% | -58.3% |
| Q4 2019 | $97,000 | -11.0% | 4,046 | 0.0% | 0.02% | -20.0% |
| Q3 2019 | $109,000 | -0.9% | 4,046 | 0.0% | 0.03% | 0.0% |
| Q2 2019 | $110,000 | +3.8% | 4,046 | +32.0% | 0.03% | 0.0% |
| Q1 2019 | $106,000 | +34.2% | 3,065 | -24.2% | 0.03% | +15.4% |
| Q4 2018 | $79,000 | -33.1% | 4,046 | -8.8% | 0.03% | -36.6% |
| Q3 2018 | $118,000 | +3.5% | 4,437 | +46.9% | 0.04% | -6.8% |
| Q2 2018 | $114,000 | +70.1% | 3,020 | +47.3% | 0.04% | +76.0% |
| Q1 2018 | $67,000 | +9.8% | 2,050 | +64.0% | 0.02% | +19.0% |
| Q4 2017 | $61,000 | -10.3% | 1,250 | 0.0% | 0.02% | -8.7% |
| Q3 2017 | $68,000 | -2.9% | 1,250 | 0.0% | 0.02% | -8.0% |
| Q2 2017 | $70,000 | +42.9% | 1,250 | 0.0% | 0.02% | +31.6% |
| Q1 2017 | $49,000 | +716.7% | 1,250 | +400.0% | 0.02% | +533.3% |
| Q4 2016 | $6,000 | 0.0% | 250 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $6,000 | +50.0% | 250 | +66.7% | 0.00% | +50.0% |
| Q2 2016 | $4,000 | +33.3% | 150 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,000 | -62.5% | 150 | 0.0% | 0.00% | -60.0% |
| Q4 2015 | $8,000 | – | 150 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |